Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 5 of 10« First...34567...10...Last »

Fingerpaint Opens Fourth Office

Fingerpaint, a full-service marketing agency with headquarters based in Saratoga Springs, New York, has opened an office in Columbus, Ohio.

Read More »

U.S. state AGs sue six cos, including Mylan, Teva, over drug pricing

Connecticut and 19 other states filed a lawsuit against Mylan, Teva Pharmaceuticals and four other generic drug makers saying they entered into illegal conspiracies that raised prices on two common generic drugs, the New York state attorney general’s office said in a statement.

Read More »

EU lawmakers urge Germany to broaden access to thalidomide fund

EU lawmakers urged Germany to grant broader access for other Europeans to its fund for thalidomide victims and for the drug’s manufacturer to provide proper compensation and care to victims not yet recognized.

Read More »

Intouch Solutions Promotes Six Chicago Employees

Intouch Solutions has announced the promotion of six employees in its Chicago office.

Read More »

Lonza to buy Capsugel from KKR for $5.5 billion

Lonza Group announced its biggest-ever acquisition with a deal to buy Capsugel, a U.S. maker of capsule products and other drug delivery systems, for $5.5 billion in cash to broaden its product range as a pharmaceuticals industry supplier.

Read More »

Booming Regeneron Buys Another Building in New York

Regeneron Pharmaceuticals is continuing to expand its physical footprint in New York’s Hudson Valley. The company snapped up a 76-acre site for $50 million, the Journal News reported.

Read More »

Pfizer’s Xtandi Flunks Late-Stage Head-to-Head Study Against Johnson & Johnson’s Zytiga

Pfizer and Astellas Pharma announced that Xtandi (enzalutamide) did not meet its top-line results in a Phase IV clinical trial.

Read More »

The 5 Most In-Demand Life Science Jobs for 2017

Although in general there are plenty of jobs in the life sciences, certain areas seem to be trending upward. Paul Strouts, global managing director of Hays Life Sciences – a worldwide recruiting firm – recently selected five areas that deserve special notice.

Read More »

FDA approves Pfizer ointment for chronic itchy skin condition

A Pfizer Inc. ointment to treat mild to moderate cases of the itchy skin condition eczema, or atopic dermatitis, won U.S. approval for use in patients aged 2 years and older, the Food and Drug Administration said.

Read More »

Express Scripts: No let-up in drug pricing chatter

Express Scripts Holding Co. – the largest pharmacy benefit manager in the United States – signaled that scrutiny into drug pricing is not going away.

Read More »

Intercept’s liver drug wins conditional EU approval

Intercept Pharmaceuticals Inc. said its liver drug received conditional approval from the European Commission to treat patients with primary biliary cholangitis (PBC).

Read More »

Siemens Healthineers’ $300 Million Expansion to Create Up to 700 New Jobs in Massachusetts

Siemens Healthineers plans to invest approximately $300 million into its Walpole, Mass. laboratory diagnostics manufacturing and research and development facility to increase its manufacturing footprint in the United States.

Read More »

INC Research Creating 550 New Jobs in HQ Move

INC Research Holdings, a contract research organization, is planning a $37.9 million investment as the company shifts from Raleigh to a new Morrisville, N.C. headquarters. The move to a larger facility will create an additional 550 jobs over the next several years, the company said.

Read More »

New diabetes guidelines imminent, Jardiance sales may surge

Two leading U.S. medical societies are poised to issue new diabetes treatment guidelines that are expected to reflect the lifesaving cardiovascular effects of Eli Lilly’s Jardiance.

Read More »

Zika virus can keep growing in infant brains even after birth: U.S. CDC

U.S. researchers have found evidence of the Zika virus replicating in fetal brains for up to seven months after the mother became infected with the virus, and they showed the virus can persist even after birth, according to a published study.

Read More »

Telemedicine for PTSD no less effective than in-person therapy

Veterans with posttraumatic stress disorder (PTSD) who have difficulties making it to in-person therapy sessions may be able to get treatment that is just as good by videoconference.

Read More »

Bristol-Myers Squibb Strengthens Capabilities with Evolution of its U.S. Geographic Footprint

Bristol-Myers Squibb Company announced important changes to its U.S. geographic footprint that will strengthen capabilities of the company’s R&D hubs of world-class science and innovation in Central New Jersey, the San Francisco Bay Area and Cambridge, Massachusetts while further integrating biologics development with clinical manufacturing at key sites to foster greater speed and collaboration.

Read More »

Lilly to offer insulin at discounted prices to certain patients

Eli Lilly and Co. said certain patients using its insulin products via a partnership with Express Scripts Holding Co. could secure a discount of up to 40 percent.

Read More »

New drug approvals dive in 2016

The global pharmaceuticals industry is set to win the lowest annual number of new drug approvals in 2016 since 2010.

Read More »

Proteon Therapeutics kidney drug fails key study

Proteon Therapeutics Inc. said its experimental chronic kidney disease drug failed to meet the main goal in a late-stage study.

Read More »

Page 5 of 10« First...34567...10...Last »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom